MOTS is on an upward trend. This biotech company has only been trading for several months and has started to trend up after testing its support at $4.35. Analyst price targets for long term have MOTS going to as much as $12. If this can break through its high of $7.87 from 12 days ago we could see a blue sky break out. On the 5min chart it is showing a bull flag.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.